SlideShare a Scribd company logo
1 of 1
Download to read offline
Behavioral Effects of Muscarinic Agonists and Antagonists on Flinders Sensitive Line Rats
Heather Cornett2, James Woods, Ph.D.1, Gail Winger, Ph.D1.
(1) University of Michigan, Department of Pharmacology, (2) College of Literature, Science, and the Arts,
University of Michigan, Ann Arbor, MI, USA
ABSTRACT
The Flinders Sensitive Line (FSL) animal model of
depression has been widely used to test well-known
antidepressants. In contrast to tolerant, normal animals, FSL
animals are more sensitive to the behavioral and hormonal effects
of muscarinic agonists and have elevated muscarinic receptors. The
primary basis for this increased sensitivity of the FSL animal is
that they have a greater number of muscarinic receptors than
normal animals. This initiative strives to determine what
physiological and/or neurological explanation there is for these
significant differences between FSL animals and normal animals.
This is accomplished by analyzing rate of response patterns in
order to gain a better understanding of the central drug effects on
both animal groups. Using operant conditioning in collaboration
with the injection of designated muscarinic agonists and
antagonists, the rate of responding of each rat was measured. It
was expected that when given equal doses of a muscarinic agonist
or antagonist, FSL rats show suppressed rates of responding,
because they are more sensitive to that drug. This hypothesis was
supported by observing rates of responding for muscarinic agonists
Arecoline and L670,548, where FSL animals showed greater
suppression in response rates than Sprague Dawley (SD) animals.
However, when given equal doses of muscarinic antagonists
Atropine and L687,306, SD animals were more suppressed than
FSL animals. Doses of diazepam were shown to have less of a
suppression effect on FSL animals than normal animals.
BACKGROUND
METHODS
• When contrasted with SD rats, FSL rats exhibit “depression-
like” qualities such as reduced body weight, elevated rapid eye-
movement during REM sleep, cognitive disabilities, and reduced
locomotor activity.
• By injecting both types of animals with various muscarinic
agonists and antagonists, the behavioral differences in the FSL
animals and normal animals are able to be observed.
• Acetylcholine is a neurotransmitter that binds to muscarinic
receptors. These receptors send messages by using the
acetylcholine neurotransmitter.
• A muscarinic agonist is a drug that mimics the actions of
acetylcholine by stimulating the acetylcholine receptors. A
muscarinic antagonist is an anticholinergic agent that blocks and
inhibits the activity of the muscarinic acetylcholine receptor.
• This research predominantly focuses on the effects of these
muscarinic agonists and antagonists on the brains of FSL and
normal animals.
• Diazepam is a drug that works at GABA receptors which reside
outside of the muscarinic system.
Subjects - 6 male SD rats and 6 male FSL rats
Testing Procedure - Each animal is injected with one of the
following drugs with corresponding pre-treatment times (PTT):
0.56 or 1.0 mg/kg Arecoline - 0min PTT
0.003 mg/kg L670,548 - 15min PTT
1.0 mg/kg Atropine - 15min PTT
0.01 mg/kg L687,306 - 0min PTT
3.0, 5.6, or 10.0 mg/kg Diazepam – 30min PTT
Animals are placed in operant conditioning boxes following their
PTT. Over the course of five components consisting of five minutes
each, each animal’s rate of responding per second is calculated and
recorded
Analysis - Each individual animal’s average per 25-minute period is
calculated. The average FSL animal’s rate of responding
(responses/second) is compared to that of the SD animals for each of
the five components.
RESULTS - ANTAGONISTS
RESULTS - AGONISTS
A.
Fig. A – When given 1.0 mg/kg Atropine with a 15 minute PTT, FSL rats had
higher rates of responding than SD rats
B.
E.
C.
Fig. B – When given 0.01 mg/kg L687,306 with no PTT, there was an
insignificant difference between FSL and SD rates of response
Fig. C – When given 0.56 mg/kg Arecoline with no PTT, FSL rats showed
lower rates of responding than SD rats
D.
Fig. D – When given 1.0 mg/kg Arecoline with no PTT, FSL rats showed
lower rates of responding than SD rats
Fig. E – When given 0.003 mg/kg L670,548 with no PTT, FSL rats showed
lower rates of responding than SD rats
CONCLUSION – FUTURE STUDY
• FSL rats were seen to be more sensitive to muscarinic agonists
than SD rats, which was evident in their heavily suppressed rates
of responding. This supported the initial hypothesis.
• When given a muscarinic antagonist, FSL rats were not suppressed
more than SD rats, and the data shows them having higher, or
nearly equal, response rates. This contradicts the initial hypothesis.
• FSL rats were less affected by Diazepam than SD rats, which is
interesting because this drug does not work at muscarinic
receptors.
• Further research will strive to solidify these claims, investigate
differences between the animals outside of the muscarinic system,
and work to understand the genetic differences of FSL rats to SD
rats.

More Related Content

What's hot

2. dose resp relationsp presentsn copy - copy
2. dose resp relationsp presentsn   copy - copy2. dose resp relationsp presentsn   copy - copy
2. dose resp relationsp presentsn copy - copy
suniu
 
Behavioural sensitisation to mk 801 is dose-dependent and
Behavioural sensitisation to mk 801 is dose-dependent andBehavioural sensitisation to mk 801 is dose-dependent and
Behavioural sensitisation to mk 801 is dose-dependent and
joaomarcos2013
 
rational use of drugs
rational use of drugsrational use of drugs
rational use of drugs
andrewkaos
 
Kiki Hooton summer undergrad research poster (4)
Kiki Hooton summer undergrad research poster (4)Kiki Hooton summer undergrad research poster (4)
Kiki Hooton summer undergrad research poster (4)
Kyrie (Kiki) Hooton
 
Cortisol, dopamine, aggression presentation
Cortisol, dopamine, aggression   presentationCortisol, dopamine, aggression   presentation
Cortisol, dopamine, aggression presentation
gustavomartinezmuniz
 
Apss2009 abstract
Apss2009 abstractApss2009 abstract
Apss2009 abstract
almanjj
 
Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16
John Gruner
 

What's hot (20)

2. dose resp relationsp presentsn copy - copy
2. dose resp relationsp presentsn   copy - copy2. dose resp relationsp presentsn   copy - copy
2. dose resp relationsp presentsn copy - copy
 
Behavioural sensitisation to mk 801 is dose-dependent and
Behavioural sensitisation to mk 801 is dose-dependent andBehavioural sensitisation to mk 801 is dose-dependent and
Behavioural sensitisation to mk 801 is dose-dependent and
 
rational use of drugs
rational use of drugsrational use of drugs
rational use of drugs
 
Kiki Hooton summer undergrad research poster (4)
Kiki Hooton summer undergrad research poster (4)Kiki Hooton summer undergrad research poster (4)
Kiki Hooton summer undergrad research poster (4)
 
Cortisol, dopamine, aggression presentation
Cortisol, dopamine, aggression   presentationCortisol, dopamine, aggression   presentation
Cortisol, dopamine, aggression presentation
 
Role of receptors in drug design
Role of receptors in drug designRole of receptors in drug design
Role of receptors in drug design
 
Overview of Pharmacodynamics
Overview of PharmacodynamicsOverview of Pharmacodynamics
Overview of Pharmacodynamics
 
Affinity and Efficacy
Affinity and EfficacyAffinity and Efficacy
Affinity and Efficacy
 
IVMS-GENERAL PRINCIPLES OF PHARMACOLOGY- Pharmacodynamics-Dose-Response Curve...
IVMS-GENERAL PRINCIPLES OF PHARMACOLOGY- Pharmacodynamics-Dose-Response Curve...IVMS-GENERAL PRINCIPLES OF PHARMACOLOGY- Pharmacodynamics-Dose-Response Curve...
IVMS-GENERAL PRINCIPLES OF PHARMACOLOGY- Pharmacodynamics-Dose-Response Curve...
 
Apss2009 abstract
Apss2009 abstractApss2009 abstract
Apss2009 abstract
 
2014 BDSRA Hofmann INCL
2014 BDSRA Hofmann INCL2014 BDSRA Hofmann INCL
2014 BDSRA Hofmann INCL
 
Journal club 15aug11
Journal club 15aug11Journal club 15aug11
Journal club 15aug11
 
Catamenial Epilepsy
Catamenial EpilepsyCatamenial Epilepsy
Catamenial Epilepsy
 
Agonists, partial agonists,
Agonists, partial agonists,Agonists, partial agonists,
Agonists, partial agonists,
 
Receptor
ReceptorReceptor
Receptor
 
Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16
 
UROP poster
UROP posterUROP poster
UROP poster
 
Novel Neuroplasticity
Novel NeuroplasticityNovel Neuroplasticity
Novel Neuroplasticity
 
Sleep and Herbal supplements
Sleep and Herbal supplementsSleep and Herbal supplements
Sleep and Herbal supplements
 
activation energy of biological system
activation energy of biological systemactivation energy of biological system
activation energy of biological system
 

Similar to POSTER

Preclinical Toxicity Studies-Tool of Drug Discovery
Preclinical Toxicity Studies-Tool of Drug DiscoveryPreclinical Toxicity Studies-Tool of Drug Discovery
Preclinical Toxicity Studies-Tool of Drug Discovery
dynajolly
 
UCSB Research Paper
UCSB Research PaperUCSB Research Paper
UCSB Research Paper
Megan Burrey
 
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...
InsideScientific
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan
Divya Krishnan
 

Similar to POSTER (20)

Screening of anti psychotic drugs salim
Screening of anti psychotic drugs  salimScreening of anti psychotic drugs  salim
Screening of anti psychotic drugs salim
 
Animal models of Anxiety and depression (ADNAN KHAN)
Animal models of Anxiety and depression (ADNAN KHAN)Animal models of Anxiety and depression (ADNAN KHAN)
Animal models of Anxiety and depression (ADNAN KHAN)
 
Anti psychotic screening methods
Anti psychotic screening methodsAnti psychotic screening methods
Anti psychotic screening methods
 
Evaluation of Antidepressant Activity of Aqueous Extract of Withania Somnifer...
Evaluation of Antidepressant Activity of Aqueous Extract of Withania Somnifer...Evaluation of Antidepressant Activity of Aqueous Extract of Withania Somnifer...
Evaluation of Antidepressant Activity of Aqueous Extract of Withania Somnifer...
 
Maze experiment details
Maze experiment detailsMaze experiment details
Maze experiment details
 
Melatonin Agonists
Melatonin AgonistsMelatonin Agonists
Melatonin Agonists
 
Thesis
ThesisThesis
Thesis
 
Preclinical Toxicity Studies-Tool of Drug Discovery
Preclinical Toxicity Studies-Tool of Drug DiscoveryPreclinical Toxicity Studies-Tool of Drug Discovery
Preclinical Toxicity Studies-Tool of Drug Discovery
 
UCSB Research Paper
UCSB Research PaperUCSB Research Paper
UCSB Research Paper
 
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...
Respiration in Anesthetized Mice: Evidence-Based Recommendations for Improved...
 
Antipsychotic screening models
Antipsychotic screening modelsAntipsychotic screening models
Antipsychotic screening models
 
Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents Preclinical Screening of Antipsychotic Agents
Preclinical Screening of Antipsychotic Agents
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan Antipsychotic screening- Dr Divya Krishnan
Antipsychotic screening- Dr Divya Krishnan
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
 
fnsys-09-00015
fnsys-09-00015fnsys-09-00015
fnsys-09-00015
 
fnsys-09-00015
fnsys-09-00015fnsys-09-00015
fnsys-09-00015
 
Animal Toxicity Studies
Animal Toxicity StudiesAnimal Toxicity Studies
Animal Toxicity Studies
 
IOFB Poster, SBN V2
IOFB Poster, SBN V2IOFB Poster, SBN V2
IOFB Poster, SBN V2
 
Animal experiments
Animal experimentsAnimal experiments
Animal experiments
 

POSTER

  • 1. Behavioral Effects of Muscarinic Agonists and Antagonists on Flinders Sensitive Line Rats Heather Cornett2, James Woods, Ph.D.1, Gail Winger, Ph.D1. (1) University of Michigan, Department of Pharmacology, (2) College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, MI, USA ABSTRACT The Flinders Sensitive Line (FSL) animal model of depression has been widely used to test well-known antidepressants. In contrast to tolerant, normal animals, FSL animals are more sensitive to the behavioral and hormonal effects of muscarinic agonists and have elevated muscarinic receptors. The primary basis for this increased sensitivity of the FSL animal is that they have a greater number of muscarinic receptors than normal animals. This initiative strives to determine what physiological and/or neurological explanation there is for these significant differences between FSL animals and normal animals. This is accomplished by analyzing rate of response patterns in order to gain a better understanding of the central drug effects on both animal groups. Using operant conditioning in collaboration with the injection of designated muscarinic agonists and antagonists, the rate of responding of each rat was measured. It was expected that when given equal doses of a muscarinic agonist or antagonist, FSL rats show suppressed rates of responding, because they are more sensitive to that drug. This hypothesis was supported by observing rates of responding for muscarinic agonists Arecoline and L670,548, where FSL animals showed greater suppression in response rates than Sprague Dawley (SD) animals. However, when given equal doses of muscarinic antagonists Atropine and L687,306, SD animals were more suppressed than FSL animals. Doses of diazepam were shown to have less of a suppression effect on FSL animals than normal animals. BACKGROUND METHODS • When contrasted with SD rats, FSL rats exhibit “depression- like” qualities such as reduced body weight, elevated rapid eye- movement during REM sleep, cognitive disabilities, and reduced locomotor activity. • By injecting both types of animals with various muscarinic agonists and antagonists, the behavioral differences in the FSL animals and normal animals are able to be observed. • Acetylcholine is a neurotransmitter that binds to muscarinic receptors. These receptors send messages by using the acetylcholine neurotransmitter. • A muscarinic agonist is a drug that mimics the actions of acetylcholine by stimulating the acetylcholine receptors. A muscarinic antagonist is an anticholinergic agent that blocks and inhibits the activity of the muscarinic acetylcholine receptor. • This research predominantly focuses on the effects of these muscarinic agonists and antagonists on the brains of FSL and normal animals. • Diazepam is a drug that works at GABA receptors which reside outside of the muscarinic system. Subjects - 6 male SD rats and 6 male FSL rats Testing Procedure - Each animal is injected with one of the following drugs with corresponding pre-treatment times (PTT): 0.56 or 1.0 mg/kg Arecoline - 0min PTT 0.003 mg/kg L670,548 - 15min PTT 1.0 mg/kg Atropine - 15min PTT 0.01 mg/kg L687,306 - 0min PTT 3.0, 5.6, or 10.0 mg/kg Diazepam – 30min PTT Animals are placed in operant conditioning boxes following their PTT. Over the course of five components consisting of five minutes each, each animal’s rate of responding per second is calculated and recorded Analysis - Each individual animal’s average per 25-minute period is calculated. The average FSL animal’s rate of responding (responses/second) is compared to that of the SD animals for each of the five components. RESULTS - ANTAGONISTS RESULTS - AGONISTS A. Fig. A – When given 1.0 mg/kg Atropine with a 15 minute PTT, FSL rats had higher rates of responding than SD rats B. E. C. Fig. B – When given 0.01 mg/kg L687,306 with no PTT, there was an insignificant difference between FSL and SD rates of response Fig. C – When given 0.56 mg/kg Arecoline with no PTT, FSL rats showed lower rates of responding than SD rats D. Fig. D – When given 1.0 mg/kg Arecoline with no PTT, FSL rats showed lower rates of responding than SD rats Fig. E – When given 0.003 mg/kg L670,548 with no PTT, FSL rats showed lower rates of responding than SD rats CONCLUSION – FUTURE STUDY • FSL rats were seen to be more sensitive to muscarinic agonists than SD rats, which was evident in their heavily suppressed rates of responding. This supported the initial hypothesis. • When given a muscarinic antagonist, FSL rats were not suppressed more than SD rats, and the data shows them having higher, or nearly equal, response rates. This contradicts the initial hypothesis. • FSL rats were less affected by Diazepam than SD rats, which is interesting because this drug does not work at muscarinic receptors. • Further research will strive to solidify these claims, investigate differences between the animals outside of the muscarinic system, and work to understand the genetic differences of FSL rats to SD rats.